Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
New Year Resolutions to Make With Your PBM
The New Year brings a slew of goals and renewal in all areas of our lives. What about your PBM program? Here’s our quick list of considerations to get your program in shape for the new year.
Property Casualty 360: The opioid epidemic in workers' comp
Employers can use these five strategies to manage opioid issues in their organizations and help injured workers heal. Read here.
Property Casualty 360: The opioid epidemic in workers' comp
Employers can use these five strategies to manage opioid issues in their organizations and help injured workers heal.
In a Data-Filled World: Stories That Rely Solely on Numbers Don’t Add Up
Storytelling sometimes seems to be a lost art. Every day we are inundated with articles that exalt big data, analytics, predictive modeling, data science, and statistics as the most compelling means of persuasion and communication.
In a Data-filled World, Stories That Rely Solely on Numbers Don’t Add Up
Storytelling sometimes seems to be a lost art. Every day we are inundated with articles that exalt big data, analytics, predictive modeling, data science, and statistics as the most compelling means of persuasion and communication. Somewhere in the fascination with all things data, we are led to conclude that data in and of itself is the end, the goal, the Shangri-La of enlightenment and understanding. That’s not the case. The numbers should provide the color to our story, not the conclusion.
Mark Pew on “The Intersection of Medicine and Disability” from NWCDC
Through our work at PRIUM, we’re constantly concerned with issues of disability and impairment as we collaborate in getting injured workers back to function.